Who
Geoffrey S. Dow
President and CEO
Company insider
Files Form 4 as: President and CEO, 60 Degrees Pharmaceuticals.
In numbers
- Trades disclosed
- 23
- Buys
- 11
- Sells
- 0
- Bought
- $146K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Jul 2023
- Last trade
- 12 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 Jun 2026filed 15 Jun 2026 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $10K7,350 at $1.38 | filing |
| 12 Jun 2026filed 15 Jun 2026 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $10K7,350 at $1.38 | filing |
| 15 Dec 2025filed 16 Dec 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $7,7369,670 at $0.80 | filing |
| 11 Dec 2025filed 12 Dec 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $3,3243,613 at $0.92 | filing |
| 10 Dec 2025filed 12 Dec 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $8,8839,350 at $0.95 | filing |
| 12 Sep 2025filed 15 Sep 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $10K7,201 at $1.39 | filing |
| 9 Jun 2025filed 9 Jun 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Code A | $13K4,376 at $2.99 | filing |
| 17 Jan 2025filed 21 Jan 2025 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —14,394 at $0.00 | filing |
| 2 Jan 2025filed 24 Jan 2025 | SXTP 60 Degrees Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —525,000 at $0.00 | filing |
| 9 Dec 2024filed 9 Dec 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $45K35,823 at $1.27 | filing |
| 6 Dec 2024filed 9 Dec 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $25K20,579 at $1.20 | filing |
| 5 Dec 2024filed 9 Dec 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $19K17,549 at $1.11 | filing |
| 21 Nov 2024filed 21 Nov 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $3,1853,500 at $0.91 | filing |
| 20 Nov 2024filed 21 Nov 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $9201,000 at $0.92 | filing |
| 19 Nov 2024filed 21 Nov 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $2,2502,500 at $0.90 | filing |
| 16 May 2024filed 21 May 2024 | SXTP 60 Degrees Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —17,000 at $0.00 | filing |
| 16 May 2024filed 21 May 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $3,74017,000 at $0.22 | filing |
| 12 Apr 2024filed 21 May 2024 | SXTP 60 Degrees Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —68,000 at $0.00 | filing |
| 12 Apr 2024filed 21 May 2024 | SXTP 60 Degrees PharmaceuticalsBiotechnology | SEC FORM 4 Code M | $18K68,000 at $0.27 | filing |
| 31 Jan 2024filed 2 Feb 2024 | SXTP 60 Degrees Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | $26025,974 at $0.01 | filing |
News
60 Degrees Pharmaceuticals Inc. (NASDAQ:SXTP) Stock Short Interest Report for SeptemberSXTP · tickerreport.com · 17 Oct 2026Head to Head Analysis: Fortress Biotech (NASDAQ:FBIO) versus 60 Degrees Pharmaceuticals (NASDAQ:SXTP)SXTP · tickerreport.com · 17 Oct 2026Critical Survey: Fortress Biotech (NASDAQ:FBIO) vs. 60 Degrees Pharmaceuticals (NASDAQ:SXTP)SXTP · tickerreport.com · 11 Oct 2026
0 headlines in the last 90 days name Geoffrey S. Dow; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.
Sectors
Related people
Nobody else traded the same names lately.